Seattle Genetics and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”), today announced dosing of the first patient...
View ArticleCerveau Technologies, Inc. Signs Research Agreement with Houston Methodist
BOSTON Cerveau Technologies Inc. today announced an agreement with Houston Methodist Hospital to support multiple projects over the next several years. These research projects are for studies of an...
View ArticleOrthocell Receives CE Mark for CelGro®
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce receipt of European regulatory approval (CE Mark) for its CelGro®...
View ArticleSosei to Advance Clinical Development in Japan of HTL0018318 in Patients with...
TOKYO & LONDON Sosei Group Corporation (“Sosei”); TSE Mothers Index:4565) announces that it has agreed with Allergan to an amendment to the 2016 global R&D and commercialisation partnership...
View ArticleFDA Accepts Otsuka’s Resubmission to Support a Regulatory Review of Tolvaptan...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has accepted Otsuka’s resubmission to support a regulatory review of Otsuka’s New Drug...
View Article武田薬品が第59回米国血液学会年次総会で血液がん治療の未来を再形成し得るデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 (ビジネスワイヤ) — 武田薬品工業株式会社(TSE:...
View ArticleMedacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium
FUKUOKA, Japan Medacta Japan, a subsidiary of Medacta International, the privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today...
View Articleモリタ東京製作所が日本における3Shape TRIOS口腔内スキャナーの販売パートナーに
東京 (ビジネスワイヤ) — 3Shapeとモリタ東京製作所は本日、モリタ東京製作所が3Shapeと契約を締結し、日本でモリタ東京製作所の歯科製品ラインを通じて、受賞歴のある3Shape TRIOS® 3口腔内スキャナーを販売することになったと発表しました。...
View ArticleGI Dynamics Receives CE Certificate of Conformity Withdrawal Notice for...
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America has received notification from its...
View ArticleGlobal Good and Motic Introduce Breakthrough AI-Powered Microscope to Fight...
XIAMEN, China & BELLEVUE, Wash. Advanced microscope designer and manufacturer Motic China Group Co., Ltd, a subsidiary of Motic (Xiamen) Electric Group Co Ltd (SHE: 300341), announced today at...
View ArticleRiboQuark Pharmaceutical Technology Co., Ltd., Announces Enrollment of The...
KUNSHAN, China Kunshan RiboQuark Pharmaceutical Technology Co., Ltd. (“RiboQuark”), a Chinese-foreign equity joint venture and clinical stage pharmaceutical company established by Suzhou Ribo Life...
View ArticleSCIEX Announces Joint Venture With Zhenjang Dian Diagnostics in China
FRAMINGHAM, Mass. & SHANGHAI SCIEX Diagnostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has...
View Articleアレクシオン、従業員が地域社会の向上を図るボランティア活動を実施する第2回年次グローバル・デー・オブ・サービスを実施
米コネティカット州ニューヘイブン (ビジネスワイヤ) —...
View ArticleNovel Antibodies against a Ground-Breaking New Target for the Treatment of...
CAMBRIDGE, England & SINGAPORE Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical...
View ArticleDr. Reddy’s Laboratories Announces the Launch of Clofarabine Injection in the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Clofarabine Injection, a therapeutic equivalent...
View ArticleMedical Electronic Systems Wins Gold Stevie® Award for YO Home Sperm Test at...
LOS ANGELES Medical Electronic Systems (MES), the gold standard in automated semen analysis and an established manufacturer of commercial-grade automated semen analyzers, was awarded the Gold...
View ArticleTakeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View Article訂正 株式会社モリタが日本における3Shape TRIOS口腔内スキャナーの販売パートナーに
東京 (ビジネスワイヤ) — 3Shapeと株式会社モリタは本日、株式会社モリタが3Shapeと契約を締結し、日本で株式会社モリタの歯科製品ラインを通じて、受賞歴のある3Shape TRIOS® 3口腔内スキャナーを販売することになったと発表しました。...
View Article武田的ADCETRIS® (brentuximab vedotin)获得CHMP肯定意见,用于治疗CD30阳性皮肤T细胞淋巴瘤
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布,欧洲药品管理局(EMA)人用药品委员会(CHMP)已采纳一项肯定意见,延长ADCETRIS® (brentuximab...
View ArticleConavi Medical and China Grand Pharmaceutical and Healthcare Enter into...
TORONTO ConaviTM Medical Inc., a privately-held company developing image guidance technologies for minimally invasive procedures, is pleased to announce that it has entered into an agreement with an...
View Article